NIH Reporter #11127376

NCI Research Grant: Studying Resistance Mechanisms in Malignant Glioma Therapy

This opportunity is a research grant from the National Cancer Institute (NCI) at the National Institutes of Health (NIH) focused on malignant glioma therapy resistance. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - OEMs and Vendors: - No specific OEMs or commercial vendors are mentioned - Products/Services Requested: - Research services in advanced single-cell lineage tracing, proteomics, and preclinical modeling - Study of brain microenvironment-dependent lineage plasticity and adaptation to targeted therapy in malignant gliomas - Expertise required in single-cell analysis, proteomics, and preclinical glioma models - Unique or Notable Requirements: - Emphasis on academic research capabilities - Focus on understanding resistance mechanisms in brain cancer - No commercial product procurement; this is a research grant opportunity - Estimated award value is approximately $41,892 - The University of California Los Angeles (UCLA) is listed as the organization location

Description

This is a research grant opportunity from the NIH/NCI focused on glioma therapy resistance mechanisms. The project involves advanced single-cell lineage tracing, proteomics, and preclinical models to study malignant gliomas. The research aims to understand how the brain microenvironment influences lineage plasticity and adaptation to targeted therapies. The project duration is from July 1, 2024, to June 30, 2029, with an award amount of approximately $41,892.

View original listing